首页 | 本学科首页   官方微博 | 高级检索  
检索        

盖诺加吡柔比星治疗晚期乳腺癌的临床观察
引用本文:陈森.盖诺加吡柔比星治疗晚期乳腺癌的临床观察[J].肿瘤基础与临床,2005,18(4):253-254.
作者姓名:陈森
作者单位:广西壮族自治区南溪山医院肿瘤科,广西,桂林,541002
摘    要:目的观察盖诺联合吡柔比星治疗晚期乳腺癌的疗效及安全性。方法对28例晚期乳腺癌患者,盖诺25mg/m2,静脉滴入,第1、8天;吡柔比星40mg/m2,静脉注射第1天,21天为一周期,全组化疗共86周期。结果有效率71.4%(20/28),CRO例,PR20例。结论盖诺加吡柔比星治疗晚期乳腺癌,疗效较好,且毒性可耐受,值得临床使用。

关 键 词:盖诺  吡柔比星  联合化疗  乳腺癌
文章编号:1003-1464(2005)04-0253-02
修稿时间:2005年3月3日

Efficacy of Navelbine(NVB) Combined with Pirarubicin(THP) in Treatment of with Advanced Breast Carcinoma Patients.
CHEN Sen.Efficacy of Navelbine(NVB) Combined with Pirarubicin(THP) in Treatment of with Advanced Breast Carcinoma Patients.[J].journal of basic and clinical oncology,2005,18(4):253-254.
Authors:CHEN Sen
Abstract:Objective To observe the therapeutic effects and toxicity of NVB combined with THP in the treatment of cases with advanced breast cancer. Methods Twenty eight cases with advanced breast cancer, the treatment consisted of NVB 25mg/m2 i v. on day 1 and day 8;THE 40mg/m2 i v. on day 1;21 days a cycle. Altogether 86 cycles were given. Results Among the 28 cases there were CR 0 case, PR 20 cases. The over all effective rate was 71.4%(20/28). Conclusion For cases with advanced of breast cancer NVB combined with THP is an effective method of treatment and the toxic effect is tolerable.
Keywords:Navelbine  Pirarubicin  combined chemotherapy  breast cancer
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号